Bioinorganic Radiochemistry, Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria.
Vienna Doctoral School in Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria.
ChemMedChem. 2024 Feb 1;19(3):e202300495. doi: 10.1002/cmdc.202300495. Epub 2024 Jan 11.
DFO* is an octadentate chelator able to form highly stable chelates with Zirconium-89 ( Zr) for nuclear medicinal applications in Positron Emission Tomography (PET). The synthesis of DFO* and its scale-up remains challenging by reported synthetic protocols. For this reason, we set out to develop a de novo synthesis of a hydroxamate-containing building block suitable for the coupling to the commercially available DFO (desferrioxamine B, mesylate salt) yielding, after deprotection, the desired chelator DFO* in a more efficient procedure. Highlights of the new synthesis of DFO* reported herein are less synthetic steps and the isolation of the desired product DFO* by using solid phase extraction (SPE), thus avoiding tedious HPLC purification. DFO* is obtained in excellent purity (92-98 %) and an overall yield of approximately 29 %. In addition, the isolated trifluoroacetic acid (TFA)-salt of DFO* displays an improved solubility in organic solvents (DMSO, DMF, methanol), which will facilitate its use for the preparation of structurally diverse derivatives suitable for bioconjugation chemistry and the development of Zr-labeled radiotracers.
DFO* 是一种八齿螯合剂,能够与锆-89(Zr)形成高度稳定的螯合物,用于正电子发射断层扫描(PET)中的核医学应用。根据报道的合成方案,DFO* 的合成及其放大仍然具有挑战性。出于这个原因,我们着手开发一种含有羟肟酸的砌块的从头合成方法,该砌块适合与商业可得的 DFO(去铁胺 B,甲磺酸盐)偶联,在更有效的程序后,脱保护后得到所需的螯合剂 DFO*。本文报道的 DFO* 新合成的重点是合成步骤更少,并且通过使用固相萃取(SPE)分离所需的产物 DFO*,从而避免繁琐的 HPLC 纯化。DFO* 的纯度(92-98%)非常高,总收率约为 29%。此外,分离得到的 DFO*三氟乙酸(TFA)盐在有机溶剂(DMSO、DMF、甲醇)中的溶解度得到改善,这将有助于其用于制备结构多样的适合生物缀合化学和锆标记放射性示踪剂开发的衍生物。